Erlotinib Hydrochloride 62332-0565-30
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 9, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA214719
Need to source Erlotinib Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
62332-0565-30Selected30 TABLET, FILM COATED in 1 BOTTLE (62332-565-30)
Other packages for this product(1)
90 TABLET, FILM COATED in 1 BOTTLE (62332-565-90)